about image

Process solutions, buffers, excipients, and a restricted selection of active pharmaceutical ingredients (APIs) are all produced by A&C, a global GMP company. We have been offering services to the life science industry since 1966, and we have grown our global footprint over time. We currently run offices and GMP production facilities throughout North America and Europe.

We are a customer-focused company that comes up with creative solutions for our clients’ GMP issues. Since we are a privately held company, transparency, quality, and flexibility are key components of our operations. A&C’s multiple quality certifications serve as proof of this:

As they are essential to our business decisions, we remain committed to ensuring that GDP and GMP are adhered to as well as that all international regulatory standards are met.

About Mastering-strategies

Choose AnItem &C produces a variety of goods at our three GMP manufacturing facilities. We began manufacturing high purity solutions on demand in 1966. Our chemicals are employed as buffers, lubricants, binders, antioxidants, process solutions, cleaning solutions, preservatives, pH adjusters, and aromatic and flavoring compounds, in addition to injectable, dermal, nasal, and ocular applications. We offer GMP customized services, including GMP custom ingredient creation, GMP custom manufacturing, and GMP custom packaging available in a range of FDA-approved formats, for all of our excipients and raw materials.

*A&C’s manufacturing locations having QMSs certified to ISO 9001:2015 are:

2019

In 2019, A&C joined two distinct Canadian biotech associations, BIOTECanada and BioAlberta, as well as North Carolina Biotech.

2018

2018 saw the awarding of a Certificate of Suitability (CEP) for 2-Phenoxyethanol API grade by EDQM and an ISO 9001:2015 certification*.

2017

With the opening of A&C Bio Buffer and a brand-new, cutting-edge manufacturing facility in Limerick, Ireland, in 2017, the company’s European expansion continued.

2016

In Baie-D’UrfĂ©, Canada, we constructed our second GMP manufacturing facility in 2016.

2015

We increased our presence in Europe in 2015 by setting up new offices in Ireland. We have been in possession of Health Canada’s Drug Establishment Licence for API manufacturing, labelling, testing, and distribution since 2015.

2014

We were granted the EXCiPACT certification for GDP and GMP in 2014. We were the first manufacturer of excipients in North America to be certified by this globally recognized accrediting body. We finished registering with the FDA to manufacture pharmaceutical ingredients that same year, and we were given approval by the agency.

2012

2012 saw us obtain the ISO 9001:2008 certification, demonstrating our unwavering dedication to quality—one of our company’s key principles.

2011

2011 saw the completion of GDP warehousing at our main manufacturing site in Canada, in addition to all GMP facility renovations. We established A&C United States and a new sales office in North Carolina.

2008

With the help of EDQM (European Directorate for the Quality of Medicines), we conducted the first Ph. Eur 6th Edition training session in Canada in 2008, demonstrating our ongoing dedication to upholding high standards of quality.

2007

A&C upgraded to a GMP environment in 2007 and proceeded with our expansion for both new and existing products.

2006

We held the inaugural USP Educational Forum Conference in Montreal in 2006. Maintaining quality as our first priority, we successfully registered the USDMF for Azelastine HCL with the FDA that same year, completing an FDA audit, a DMF review, and a Manufacturer approval.

1990

The product line was expanded in 1990 with the addition of cleaning and buffer solutions, which caused the plant’s production and warehouse to double.

1975

After USP Reference Standards were distributed, A&C was recognized as the world’s oldest USP distributor in 1975.

1966

In 1966, we constructed our first facility in Montreal, Canada, to handle a rise in sales as well as the development and expansion of new products. For more than 25 years, the company’s annual growth was mostly driven by the production of laboratory chemicals and fine chemicals.

2019

In 2019, A&C became member of North Carolina Biotech and of two separate Canadian biotech associations named BIOTECanada and BioAlberta.

2018

In 2018, we received the ISO 9001:2015 certification* and a Certificate of Suitability (CEP) for 2-Phenoxyethanol API grade awarded by EDQM.

2017

The expansion into Europe continued in 2017 with the opening of A&C Bio Buffer and a new state-of-the-art manufacturing facility in Limerick, Ireland

2016

In 2016, we built our second GMP manufacturing facility in Baie-D’Urfé, Canada.

2015

In 2015 we expanded into Europe and opened new offices in Ireland. Since 2015, we have been holding the Drug Establishment Licence for API manufacturing, labelling, testing and distribution issued by Health Canada.

2014

In 2014 we received the EXCiPACT certification for GMP and GDP. We were the first excipient manufacturer in North America to receive the certification from this world renowned accreditation body. In that same year, we completed our registration with FDA for pharmaceutical ingredient manufacturing and we received FDA approval.

2012

We received the ISO 9001:2008 certification in 2012, showing continuous commitment to quality, one of the core values of our company.

2011

In 2011 we completed all GMP facility renovations, as well as GDP warehousing at our main manufacturing site in Canada. A&C United States was launched and we opened a new sales office in North Carolina.

2008

In 2008, we held the first Ph. Eur 6th Edition training session in Canada with EDQM (European Directorate for the Quality of Medicines) which demonstrated our continuous focus and commitment on keeping high quality standards.

2007

In 2007, A&C continued our expansion and upgraded towards GMP environment for both our new and existing products.

2006

In 2006 we hosted the first USP Educational Forum Conference in Montreal. Keeping quality at the core of our business, in that same year, we successfully registered USDMF for Azelastine HCL with FDA, which included an FDA audit, a DMF review, and a Manufacturer approval.

1990

In 1990, buffer and cleaning solutions were introduced to the product range which led to a plant expansion as production and warehouse doubled.

1975

In 1975, following the distribution of USP Reference Standards, A&C was awarded the oldest USP distributor worldwide.

1966

Our first facility was built in Montreal, Canada in 1966 to accommodate an increase in sales and to allow new product development and growth. For over 25 years the business continued to grow yearly mainly with fine chemicals and laboratory chemical manufacturing.

Scroll to Top